Hypoaldosteronism risk factors: Difference between revisions

Jump to navigation Jump to search
Line 33: Line 33:
*Less common risk factors in the development of [disease name] include:<ref name="pmid8222376">{{cite journal |vauthors=Shaked Y, Blau A, Shpilberg O, Samra Y |title=Hyporeninemic hypoaldosteronism associated with multiple myeloma: 11 years of follow-up |journal=Clin. Nephrol. |volume=40 |issue=2 |pages=79–82 |year=1993 |pmid=8222376 |doi= |url=}}</ref>
*Less common risk factors in the development of [disease name] include:<ref name="pmid8222376">{{cite journal |vauthors=Shaked Y, Blau A, Shpilberg O, Samra Y |title=Hyporeninemic hypoaldosteronism associated with multiple myeloma: 11 years of follow-up |journal=Clin. Nephrol. |volume=40 |issue=2 |pages=79–82 |year=1993 |pmid=8222376 |doi= |url=}}</ref>
**Multiple myeloma
**Multiple myeloma
**[risk factor 2]
**SLE-associated renal disease.
**[risk factor 3]
**[risk factor 3]



Revision as of 18:48, 25 August 2017

Hypoaldosteronism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypoaldosteronism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypoaldosteronism risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypoaldosteronism risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypoaldosteronism risk factors

CDC on Hypoaldosteronism risk factors

Hypoaldosteronism risk factors in the news

Blogs on Hypoaldosteronism risk factors

Directions to Hospitals Treating Hypoaldosteronism

Risk calculators and risk factors for Hypoaldosteronism risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ==Overview==[1] There are no established risk factors for [disease name].

OR

The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.

Risk Factors

  • There are no established risk factors for [disease name].

OR

  • The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
  • Common risk factors in the development of [disease name] include Diabetes mellitus, [risk factor 2], [risk factor 3], and [risk factor 4].

===Common Risk Factors===[2][3]

  • Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
  • Common risk factors in the development of [disease name] include:

Less Common Risk Factors

  • Less common risk factors in the development of [disease name] include:[4]
    • Multiple myeloma
    • SLE-associated renal disease.
    • [risk factor 3]

References

  1. Liamis G, Liberopoulos E, Barkas F, Elisaf M (2014). "Diabetes mellitus and electrolyte disorders". World J Clin Cases. 2 (10): 488–96. doi:10.12998/wjcc.v2.i10.488. PMC 4198400. PMID 25325058.
  2. Uribarri J, Oh MS, Carroll HJ (1990). "Hyperkalemia in diabetes mellitus". J Diabet Complications. 4 (1): 3–7. PMID 2141843.
  3. Bojestig M, Nystrom FH, Arnqvist HJ, Ludvigsson J, Karlberg BE (2000). "The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes". J Renin Angiotensin Aldosterone Syst. 1 (4): 353–6. doi:10.3317/jraas.2000.065. PMID 11967822.
  4. Shaked Y, Blau A, Shpilberg O, Samra Y (1993). "Hyporeninemic hypoaldosteronism associated with multiple myeloma: 11 years of follow-up". Clin. Nephrol. 40 (2): 79–82. PMID 8222376.

Template:WH Template:WS